Form 13-F position report

EDWARDS LIFESCIENCES CORP

Reported by ALLIANCEBERNSTEIN L P

EW CUSIP 28176E108 Manager CIK 0001109448

Reported 7,557,934 shares, down 1,102,482 (12.7%) from the prior quarter.

Reported value -5.9%; share count -12.7% vs. the prior quarter.

Reduced
% of reported 13F value 0.2% This manager · Q3 2026
Shares 7,557,934 Quarter-end amount reported
Reported value $652,880,365 Fair value at quarter end
Consecutive quarters held 54 Through Q3 2026

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 1735778000
2022-03-31 1657326000
2022-06-30 1555871000
2022-09-30 1418052000
2022-12-31 1632040031
2023-03-31 1691453899
2023-06-30 1934919128
2023-09-30 1575545807
2023-12-31 1455509029
2024-03-31 1567731654
2024-06-30 1878911841
2024-09-30 460825261
2024-12-31 150923258
2025-03-31 83848778
2025-06-30 86257027
2025-09-30 80276449
2025-12-31 214172211
2026-03-31 295592014
2026-06-30 693526113
2026-09-30 652880365

Quarterly position history

How this manager's reported quarter-end position changed over time.

20 quarters
Quarterly reported position history for EDWARDS LIFESCIENCES CORP held by ALLIANCEBERNSTEIN L P.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 Reduced 7,557,934 -1,102,482 (-12.7%) 0.2% $652,880,365 2026-11-16
Q2 2026 Added 8,660,416 +5,193,061 (149.8%) 0.23% $693,526,113 2026-08-14
Q1 2026 Added 3,467,355 +955,071 (38.0%) 0.1% $295,592,014 2026-05-15
Q4 2025 Added 2,512,284 +1,480,055 (143.4%) 0.07% $214,172,211 2026-02-17
Q3 2025 Reduced 1,032,229 -70,661 (-6.4%) 0.03% $80,276,449 2025-11-14
Q2 2025 Reduced 1,102,890 -53,964 (-4.7%) 0.03% $86,257,027 2025-08-14
Q1 2025 Reduced 1,156,854 -881,823 (-43.3%) 0.03% $83,848,778 2025-05-15
Q4 2024 Reduced 2,038,677 -4,944,582 (-70.8%) 0.05% $150,923,258 2025-02-12
Q3 2024 Reduced 6,983,259 -13,357,889 (-65.7%) 0.15% $460,825,261 2024-11-14
Q2 2024 Added 20,341,148 +3,935,417 (24.0%) 0.66% $1,878,911,841 2024-08-14
Q1 2024 Reduced 16,405,731 -2,682,912 (-14.1%) 0.55% $1,567,731,654 2024-05-14
Q4 2023 Reduced 19,088,643 -3,653,069 (-16.1%) 0.56% $1,455,509,029 2024-02-14
Q3 2023 Added 22,741,712 +2,229,477 (10.9%) 0.67% $1,575,545,807 2023-11-14
Q2 2023 Added 20,512,235 +66,763 (0.3%) 0.79% $1,934,919,128 2023-08-15
Q1 2023 Reduced 20,445,472 -1,428,808 (-6.5%) 0.72% $1,691,453,899 2023-05-15
Q4 2022 Added 21,874,280 +4,712,819 (27.5%) 0.73% $1,632,040,031 2023-02-15
Q3 2022 Added 17,161,461 +799,376 (4.9%) 0.69% $1,418,052,000 2022-11-15
Q2 2022 Added 16,362,085 +2,283,544 (16.2%) 0.71% $1,555,871,000 2022-08-15
Q1 2022 Added 14,078,541 +680,021 (5.1%) 0.64% $1,657,326,000 2022-05-13
Q4 2021 Added 13,398,520 +583,209 (4.6%) 0.61% $1,735,778,000 2022-02-14
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

1438 managers reported EDWARDS LIFESCIENCES CORP for Q3 2026.

Managers reporting EDWARDS LIFESCIENCES CORP in Q3 2026.
Manager Activity Shares Change % of reported 13F Reported value Tenure
BlackRock Inc Reduced 58,746,896 -42,537 0.07% $5,071,032,119 9 qtrs
VANGUARD CAPITAL MANAGEMENT LLC Added 37,717,944 +101,992 0.07% $3,255,812,926 3 qtrs
STATE STREET CORPORATION Added 26,546,099 +224,159 0.07% $2,291,459,266 44 qtrs
VANGUARD PORTFOLIO MANAGEMENT LLC Added 26,483,306 +71,904 0.1% $2,286,038,974 3 qtrs
JPMorgan Chase & Co Added 24,464,600 +1,681,425 0.12% $2,154,842,045 54 qtrs
WELLINGTON MANAGEMENT GROUP LLP Added 16,876,681 +48,714 0.26% $1,456,795,104 54 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 15,605,804 +168,553 0.07% $1,341,765,563 54 qtrs
Ninety One UK Ltd Reduced 11,943,675 -393,827 2.27% $1,030,978,043 14 qtrs
THE BANK OF NEW YORK MELLON CORPORATION Reduced 11,280,393 -2,804,090 0.16% $973,723,491 54 qtrs
DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main Reduced 10,700,967 -2,301,998 0.69% $923,708,338 40 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2026
Filed
November 16, 2026
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
6,953,841
Shared
0
None
604,093

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.